University Hospital La Paz - Carlos III

Spain - Madrid

Go to:

Specialists in this centre

Staff Neurologist

Madrid,Spain

Closed for participation

In this study, an investigational oral drug named dazucorilant (also called CORT113176) is being studied in people living with ALS.

Archived

Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of FNP122 for people with ALS.

If you would like to contact us or register for a trial, leave your details here.